Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension of Subcutaneous LY2127399 in Japanese Rheumatoid Arthritis Patients on Methotrexate
jRCT2080221102Phase 1
- Sponsor
- Eli Lilly and Company
- Start
- May 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tabalumab in rheumatoid arthritis (RA), sponsored by Eli Lilly and Company.
02
Drugs
tabalumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080221102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221102.